News Website

Nancy Lem clitoral massager deal: $66.75 ($90 off) - Mashable

Nancy Lem clitoral massager deal: $66.75 ($90 off) Mashable

Published: March 3, 2026, 7:46 a.m.

Read Full Article

Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study - Cureus

Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study Cureus

Published: Feb. 27, 2026, 7:22 a.m.

Read Full Article

Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients - geneonline.com

Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients geneonline.com

Published: Feb. 16, 2026, 10:55 a.m.

Read Full Article

Oral Microcapsules Encapsulating Endometrial Regenerative Cell-Derived | IJN - Dove Medical Press

Oral Microcapsules Encapsulating Endometrial Regenerative Cell-Derived | IJN Dove Medical Press

Published: Feb. 2, 2026, 7:47 a.m.

Read Full Article

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - The Manila Times

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress The Manila Times

Published: Jan. 23, 2026, 1:20 p.m.

Read Full Article

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - manilatimes.net

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress manilatimes.net

Published: Jan. 23, 2026, 1:20 p.m.

Read Full Article

‘The Moral Property of Women’: Mifepristone as Contraception. Who Gets to Decide? - Ms. Magazine

‘The Moral Property of Women’: Mifepristone as Contraception. Who Gets to Decide? Ms. Magazine

Published: Jan. 22, 2026, 12:02 p.m.

Read Full Article

New oral contrast agent helps spot 'previously impossible-to-detect' findings on CT - Radiology Business

New oral contrast agent helps spot 'previously impossible-to-detect' findings on CT Radiology Business

Published: Jan. 21, 2026, 10:16 p.m.

Read Full Article

‘The Moral Property of Women’: Mifepristone Could Treat Endometriosis, Some Cancers, Depression and Chronic Illness—If Politics Didn’t Interfere - Ms. Magazine

‘The Moral Property of Women’: Mifepristone Could Treat Endometriosis, Some Cancers, Depression and Chronic Illness—If Politics Didn’t Interfere Ms. Magazine

Published: Jan. 21, 2026, 12:05 p.m.

Read Full Article

'The Moral Property of Women': Mifepristone, Fibroids and the Stakes of Suppressed Science - Ms. Magazine

'The Moral Property of Women': Mifepristone, Fibroids and the Stakes of Suppressed Science Ms. Magazine

Published: Jan. 20, 2026, 12:05 p.m.

Read Full Article

Latest Articles

Nancy Lem clitoral massager deal: $66.75 ($90 off) - Mashable

Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study - Cureus

Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients - geneonline.com

Oral Microcapsules Encapsulating Endometrial Regenerative Cell-Derived | IJN - Dove Medical Press

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - The Manila Times

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - manilatimes.net

‘The Moral Property of Women’: Mifepristone as Contraception. Who Gets to Decide? - Ms. Magazine

New oral contrast agent helps spot 'previously impossible-to-detect' findings on CT - Radiology Business

‘The Moral Property of Women’: Mifepristone Could Treat Endometriosis, Some Cancers, Depression and Chronic Illness—If Politics Didn’t Interfere - Ms. Magazine

'The Moral Property of Women': Mifepristone, Fibroids and the Stakes of Suppressed Science - Ms. Magazine

Subscribe to Our Newsletter